Akorn (AKRX) Q3 2019 Earnings Call Transcript
AKRX earnings call for the period ending September 30, 2019.
The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.
AKRX earnings call for the period ending September 30, 2019.
AKRX earnings call for the period ending June 30, 2019.
AKRX earnings call for the period ending March 31, 2019.
The embattled generic-pharmaceutical manufacturer earned two new product approvals.
AKRX earnings call for the period ending December 31, 2018.
It looks as if the company's former suitor will get a chance to run from the altar.
A judge gave Fresenius the green light to walk away from the now-infamous merger.
Learn why these stocks missed the rally.
It's official: A judge ruled that Fresenius can abandon the previously announced acquisition of Akorn.
The rift with Fresenius continues to make headlines.